IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib. [electronic resource]
Producer: 20180115Description: 42031-42044 p. digitalISSN:- 1949-2553
- A549 Cells
- Animals
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Drug Resistance, Neoplasm
- Epithelial-Mesenchymal Transition
- ErbB Receptors -- metabolism
- Erlotinib Hydrochloride -- therapeutic use
- Female
- Gefitinib
- Humans
- Interleukin-8 -- metabolism
- Lung Neoplasms -- drug therapy
- Mice
- Mice, Nude
- Mutation
- Neoplasm Transplantation
- Phenotype
- Quinazolines -- therapeutic use
- Signal Transduction
- Up-Regulation
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.